Cargando…

G6PD Maintains Redox Homeostasis and Biosynthesis in LKB1-Deficient KRAS-Driven Lung Cancer

Cancer cells depend on nicotinamide adenine dinucleotide phosphate (NADPH) to combat oxidative stress and support reductive biosynthesis. One major NAPDH production route is the oxidative pentose phosphate pathway (committed step: glucose-6-phosphate dehydrogenase, G6PD). Alternatives exist and can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Taijin, Arastu, Sara, Wang, Samuel, Lam, Jarrick, Wang, Wenping, Bhatt, Vrushank, Lopes, Eduardo Cararo, Hu, Zhixian, Sun, Michael, Luo, Xuefei, Ghergurovich, Jonathan M., Li, Changlong, Su, Xiaoyang, Rabinowitz, Joshua D., White, Eileen, Guo, Jessie Yanxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592603/ https://www.ncbi.nlm.nih.gov/pubmed/37873106 http://dx.doi.org/10.1101/2023.10.06.561131

Ejemplares similares

Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors
por: Bhatt, Vrushank, et al.
Publicado: (2023)

Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis
por: Bhatt, Vrushank, et al.
Publicado: (2019)

Autophagy compensates for Lkb1 loss to maintain adult mice homeostasis and survival
por: Khayati, Khoosheh, et al.
Publicado: (2020)

Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration
por: Huo, Yanying, et al.
Publicado: (2022)

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
por: Kim, Jiyeon, et al.
Publicado: (2017)

Autophagy maintains tumor growth through circulating arginine
por: Poillet-Perez, Laura, et al.
Publicado: (2018)

The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1-mutant lung cancer
por: Kim, Jiyeon, et al.
Publicado: (2020)

Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022)

Lkb1 maintains T(reg) cell lineage identity
por: Wu, Di, et al.
Publicado: (2017)

KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
por: Gu, Meichen, et al.
Publicado: (2021)

Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells
por: Guo, Jessie Yanxiang, et al.
Publicado: (2016)

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022)

LKB1 and AMPK maintain epithelial cell polarity under energetic stress
por: Mirouse, Vincent, et al.
Publicado: (2007)

LKB1 and AMPK maintain epithelial cell polarity under energetic stress
por: Mirouse, Vincent, et al.
Publicado: (2013)

CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer
por: Jariwala, Nidhi, et al.
Publicado: (2021)

Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation
por: Tong, Xinyuan, et al.
Publicado: (2021)

Targeting PGM3 as a Novel Therapeutic Strategy in KRAS/LKB1 Co-Mutant Lung Cancer
por: Lee, Hyunmin, et al.
Publicado: (2022)

LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest
por: Morton, Jennifer P., et al.
Publicado: (2010)

Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status
por: Zhang, Jun, et al.
Publicado: (2017)

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
por: Meraz, Ismail M., et al.
Publicado: (2022)

LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
por: Zhou, Wei, et al.
Publicado: (2014)

Autophagy, Metabolism, and Cancer
por: Guo, Jessie Yanxiang, et al.
Publicado: (2017)

SOX4-SMARCA4 complex promotes glycolysis-dependent TNBC cell growth through transcriptional regulation of Hexokinase 2
por: Khanna, Pooja, et al.
Publicado: (2023)

Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
por: Huang, Dan, et al.
Publicado: (2023)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022)

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition
por: Mahoney, C L, et al.
Publicado: (2009)

Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS‐LKB1 co‐mutated lung cancer cells
por: Han, Jang Hee, et al.
Publicado: (2022)

Increased PD-L1 expression in KRAS mutated premalignant human bronchial epithelial cells is enhanced by LKB1 loss and mediated by ERK activation
por: Lee, Mi-Heon, et al.
Publicado: (2015)

Mild Oxidative Stress Reduces NRF2 SUMOylation to Promote Kras/Lkb1/Keap1 Mutant Lung Adenocarcinoma Cell Migration and Invasion
por: Xu, Jiaqian, et al.
Publicado: (2020)

Multistability maintains redox homeostasis in human cells
por: Huang, Jo‐Hsi, et al.
Publicado: (2021)

LKB1 as the ghostwriter of crypt history
por: Jansen, Marnix, et al.
Publicado: (2011)

AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015)

LKB1 in transmembrane receptor signaling
por: Okon, Imoh S., et al.
Publicado: (2015)

Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition
por: Huynh, Minh V., et al.
Publicado: (2022)

Two NAD-linked redox shuttles maintain the peroxisomal redox balance in Saccharomyces cerevisiae
por: Al-Saryi, Nadal A., et al.
Publicado: (2017)

Methionine synthase supports tumor tetrahydrofolate pools
por: Ghergurovich, Jonathan M., et al.
Publicado: (2021)

The Cutaneous Physiological Redox: Essential to Maintain but Difficult to Define
por: Ron-Doitch, Sapir, et al.
Publicado: (2020)

Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status
por: Xiao, Zhiguang, et al.
Publicado: (2014)

Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer
por: Zhang, Donghong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fr283l2jcjgfmumhl39oj6vsn6